TRIM27 belongs to the RET/PTC (Rearranged in Transformation/Papillary Thyroid Carcinomas) fusion protein subfamily that is involved in oncogenic actions, and the RET proto-oncogene domain of this subfamily is considered essential for its oncogenic potential [24, 25]. Here, RET is linked to thyroid gland papillary carcinoma.